الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
31 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
32 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Amany Mohammed Abdel Moatamed 2023
34 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
35 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
36 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Osama mostafa Abdelbadee Abou elhassan 2021
37 Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: a possible prognostic marker
 		Dr. Hanaan Ahmed Mohammed Ahmed 2021
38 Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents Dr. Hanaan Ahmed Mohammed Ahmed 2021
39 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Ahmed Refaat Abdel Zaher Mubarak 2021
40 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Adel Gomaa Mohamed Gabr 2021